目的：介绍经股浅动脉入路药盒植入术并发症及相应处理方法。材料与方法：６０例，男５３例，女７例，平均年龄４９岁。无栓塞适应症的原发性肝癌３６例，转移性肝癌１４例，其他晚期肿瘤１０例。均经股浅动脉植入药盒。结果：随访时间最长１８个月，药盒导管移位５例（８．３％），靶血管闭塞２例（３．３％），药盒导管闭塞３例（５．５％）。伤口延迟愈合１例（１．６％）。导管移位者均采用介入技术调整导管至腹主动脉，药盒导管闭塞溶栓再通１例，取出药盒及导管经对侧股动脉再植入１例。结论：经股浅动脉入路药盒植入术成功率高，并发症少。熟练的介入技术可避免或减少并发症并能成功地处理相应并发症 Objective: To introduce the complications of transfemoral superficial femoral approach kit implantation and the corresponding treatment methods. Materials and Methods: 60 cases, 53 males and 7 females, with an average age of 49 years. There were 36 cases of primary liver cancer without embolism, 14 cases of metastatic liver cancer, and 10 cases of other advanced tumors. All were superficial femoral artery implant kits. Results: The longest follow-up time was 18 months. Five cases (8.3%) of catheters were transposed in the drug cartridges, 2 (3.3%) were occluded in target vessels, and 3 cases (5.5%) were occluded in the cartridges. Wound delayed healing in one case (1.6%). The catheter shifters used interventional techniques to adjust the catheter to the abdominal aorta. The catheter was occluded and thrombolysis was performed in 1 patient. The patient and the catheter were removed and the contralateral femoral artery was implanted in 1 patient. Conclusion: The implantation of the superficial femoral artery approach has high success rate and fewer complications. Skilled intervention techniques can avoid or reduce complications and successfully manage the corresponding complications